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XenopusEBF proteins have diverse functions in the development of multiple lineages, including neurons, B cells and
adipocytes. During Drosophilamuscle development EBF proteins are expressed in muscle progenitors and are
required for muscle cell differentiation, but there is no known function of EBF proteins in vertebrate muscle
development. In this study, we examine the expression of ebf genes in Xenopus muscle tissue and show that
EBF activity is necessary for aspects of Xenopus skeletal muscle development, including somite organization,
migration of hypaxial muscle anlagen toward the ventral abdomen, and development of jaw muscle. From a
microarray screen, we have identiﬁed multiple candidate targets of EBF activity with known roles in muscle
development. The candidate targets we have veriﬁed are MYOD, MYF5, M-Cadherin and SEB-4. In vivo
overexpression of the ebf2 and ebf3 genes leads to ectopic expression of these candidate targets, and
knockdown of EBF activity causes downregulation of the endogenous expression of the candidate targets.
Furthermore, we found that MYOD and MYF5 are likely to be direct targets. Finally we show that MYOD can
upregulate the expression of ebf genes, indicating the presence of a positive feedback loop between EBF and
MYOD that we ﬁnd to be important for maintenance of MYOD expression in Xenopus. These results suggest
that EBF activity is important for both stabilizing commitment and driving aspects of differentiation in
Xenopus muscle cells.gy and Anatomy, University of
ty, UT 84132, USA. Fax:+1 801
een),
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The processes of cell commitment and cell differentiation are
important aspects of the development of muscle tissue. The group of
transcription factors known as myogenic regulatory factors (MRFs),
which includes the proteins MYOD and MYF5, is critical in driving
both commitment and differentiation in muscle tissue, as seen by the
complete lack of muscle cells in Myod, Myf5 double knockout mice
(Rudnicki et al., 1993). Additional transcription factors also regulate
aspects of muscle development, often as part of the MRF regulatory
network. In Drosophila, the Early B cell factor (EBF, also known as COE
(collier/olfactory/EBF)) family member Collier plays a role in muscle
development, but the roles of EBF proteins in vertebrate muscle
development have not been explored.
EBF family members are transcription factors involved in devel-
opment in several different cell lineages, including neurons, B cells,
adipocytes and muscle cells (reviewed in (Dubois and Vincent, 2001;
Liberg et al., 2002; Lukin et al., 2008)). These proteins contain a zinc
ﬁnger DNA binding domain and an atypical helix–loop–helix
dimerization domain (Hagman et al., 1993; Hagman et al., 1995;Wang et al., 1997; Wang and Reed, 1993). There are four family
members in mammals (EBF1, EBF2, EBF3 and O/E4), two known
members in Xenopus (EBF2 and EBF3), and one in zebraﬁsh (ZCOE2)
(Bally-Cuif et al., 1998; Dubois et al., 1998; Garel et al., 1997; Hagman
et al., 1993; Malgaretti et al., 1997; Pozzoli et al., 2001; Wang et al.,
1997; Wang and Reed, 1993). Among invertebrates, the proteins
Collier in Drosophila and UNC3 (CeO/E) in C. elegans belong to the EBF
family (Crozatier et al., 1996; Prasad et al., 1998).
In Drosophila, the collier gene is expressed in progenitors for
several muscles, and is required for myoblast fusion (Crozatier and
Vincent, 1999). The expression of collier in Drosophila is driven by
both Collier itself and by the MYOD ortholog Nautilus, and this
upregulation is synergistic when the two genes are present together
(Dubois et al., 2007). In Xenopus and mouse, Northern blot analysis
and RNase protection assays show that Ebf2 and Ebf3 are expressed in
adult muscle (Dubois et al., 1998; Garel et al., 1997; Malgaretti et al.,
1997) Furthermore, EBF proteins are known to bind to the negative
regulatory element of the glut4 gene in muscle (Dowell and Cooke,
2002), which allows for insulin-mediated glucose uptake in multiple
tissue types (Kahn, 1998). However, the exact expression patterns,
transcriptional targets, and functions of EBF genes in the development
of vertebrate muscle are not understood.
The process of muscle development has been intensively investi-
gated in multiple vertebrate models, including Xenopus. During
vertebrate development, early mesoderm tissue forms somites, which
contain myotome cells that will become myoblasts and give rise to
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early rotational event that gives rise to somites (reviewed in (Elinson,
2007)). Somites contain two separatemuscle cell lineages. The region of
the somite called the dermamyotome contains a dorsal lip, near the
neural tube, with cells that will form epaxial muscles (muscles of the
deepback), and a ventral lip, far from theneural tube,with cells thatwill
form hypaxialmuscles (muscles of the bodywall and limbs) (Gros et al.,
2005;Mariani et al., 2001). InXenopus thehypaxial cells budoff fromthe
somite andmigrate ventrally along the bodywall before completing the
processes of muscle development (Martin and Harland, 2001; Martin
and Harland, 2006). Next, myoblasts localize to their correct positions
and exit the cell cycle. In most species, myoblasts then align with
neighboring myoblasts, undergo fusion, and continue differentiation as
multinucleated muscle ﬁbers. However, in Xenopus, muscle cells
generated before metamorphosis utilize amitotic rounds of nuclear
division to generate multi-nucleated muscle cells (Boudjelida and
Muntz, 1987; Kielbowna, 1966).
Acrossmany species,MYODandMYF5are expressed fromthesomite
stage. In Xenopus, MYOD and MYF5 are expressed even in presomitic
mesoderm (Dosch et al., 1997; Hopwood et al., 1989; Hopwood et al.,
1991), and when MYF5 function is blocked by morpholinos, normal
development of both the presomitic mesoderm region and of somites is
disrupted (Keren et al., 2005). MYOD and MYF5 are also expressed in
Xenopusmigrating hypaxial cells (Martin and Harland, 2001).
To identify transcriptional targets for EBF factors, we performed a
microarray screen of Xenopus animal cap tissuewith active EBF3 protein
(Green and Vetter, 2011), and unexpectedly found that several muscle-
related genes were among the most strongly up-regulated targets,
suggesting a role for EBF factors in regulating vertebrate muscle
differentiation. Here, we demonstrate the sufﬁciency and requirement
of EBF2 and EBF3 for in vivo expression of the muscle-related genes
myod,myf5, seb-4 (also called rbm24), andm-cadherin, identiﬁed in our
microarray screen.We also describe the expression patterns of ebf2 and
ebf3 in the tissues that give rise to Xenopus skeletal muscle, and show a
requirement for EBF2 and EBF3 activity in normal muscle development.
Finally,weprovideevidence thatmyf5 andmyodare direct targets of EBF
activity and thatMYODcandrive expressionof ebf2 and ebf3, in vivo. Our
results suggest several new functions of EBF proteins in vertebrate
muscledevelopment, andprovide evidence invertebratesof a reciprocal
transcriptional relationship between EBF proteins and MYOD.
Materials and methods
Microinjection of RNA and morpholinos
The following constructs were used as DNA templates to make
capped RNA: pCS2+Noggin (Lamb et al., 1993), pCS2+hGR-MT-
Xebf2, pCS2+hGR-MT-Xebf3, pCS2+NLS-DN-EBF, p64T-MyoD-GR
(Kolm and Sive, 1995), and pCS2+nβgal (Chitnis et al., 1995). Capped
RNA was generated in vitro using the Message mMachine kit
(Ambion). Antisense morpholino oligonucleotides (MOs) were
designed by Gene Tools, and directed against a region at or near the
translational start site of ebf2 (5′-GCGCTTTGTCTCTCAAGGCAGTTCC-
3′) and ebf3 (5′-GTATATTTTCCTGAATCCCAAACAT-3′).
For testing sufﬁciency of EBF and MYOD to drive target gene
expression, a volume of 4 nl containing RNA was injected into one
blastomere of two cell stage embryos. The following amounts of
capped RNA were used for injection: hGR-Xebf2 (0.5 ng for over-
expression and 50 pg for coinjection with MOs), hGR-Xebf3 (0.5 ng),
MyoD-hGR (0.5 ng for overexpression and 25 pg for coinjection with
MOs)), and nuclear β-galactosidase (nβgal, 30 pg). For morpholino
experiments, each of two vegetal blastomeres of 8-cell stage embryos
were injected with EBF2 MO (Gene Tools, 7.5 ng or 10 ng), EBF3 MO
(Gene Tools, 7.5 ng or 10 ng), and capped mRNA encoding nβgal
(20 pg). CappedmRNA encoding NLS-DN-EBF (1 ng) was also injected
into two vegetal blastomeres of 8-cell stage embryos. In allmicroinjections, nβgal capped mRNA was co-injected with other
cappedmRNA ormorpholinos into embryos as a tracer. Embryoswere
then grown and staged (Nieuwkoop and Faber, 1994). Embryos,
which were injected with mRNA encoding hGR-XEBF2, hGR-XEBF3
andMYOD-hGR, were treated with 30 μMDEX from the gastrula stage
(stage 11/11.5) to the neurula stage (stage 14/15), which is 6–8 h at
room temperature. Alternatively, embryos injected with hGR-XEBF3
mRNA were treated with 30 μM DEX from the blastula stage (stage 9)
for 4.5 h (to the gastrula stage (stage 10.5–11)) at 23 °C. All embryos
were then ﬁxed with 4% paraformaldehyde (PFA) in PBS for 30 min.
After washing the embryos 3 times with PBS, X-gal staining was
performed as described (Turner and Weintraub, 1994). Further
ﬁxation was done for 1 h at room temperature or overnight at 4 °C.
Reverse transcriptase PCR
For reverse transcriptase PCR (RT-PCR) experiments, 1 ng hGR-
XEBF3 mRNA and/or 0.2 ng Noggin mRNA were injected into Xenopus
embryos at the one-cell stage, and animal capswere isolated at stage 9. If
the embryos were injected with hGR-XEBF3 mRNA, animal caps from
the embryosweredivided into twogroups,with one groupbeing treated
with DEX for 4.5 h, (during which time sibling embryos reached stage
11–11.5), and the other used as a non-treated control. For another
control, animal caps were isolated from uninjected sibling embryos.
Total RNA was isolated from the animal caps with Trizol (Invitrogen),
genomic DNAwas removedwith the RNeasymini kit (Qiagen), and then
the total RNA was extracted with phenol/chloroform. To make cDNA
from isolated total RNA from animal caps, SuperScript III RT (Invitrogen)
was used according to the manufacturer's instructions. MacVector
Software was used to design the gene speciﬁc primers (Supplemental
Table 1). PCR was performed as previously described (Hutcheson and
Vetter, 2001; Pozzoli et al., 2001). RT-PCR for brachyurywas performed
to ensure that there was no mesoderm contamination in animal caps.
We also conﬁrmed that muscle actin was not expressed in uninjected or
untreated caps, further conﬁrming the lack of mesoderm contamination
(Supplemental Fig. 1). The primer sequences for muscle actin were
obtained from Xenbase (http://www.xenbase.org/other/static/
methods/RT-PCR.jsp).
Whole mount in situ hybridization
The following constructs were used to generate antisense RNA
probes: pBS-Xebf2 (Pozzoli et al., 2001), pBS-Xebf3 (Pozzoli et al.,
2001), pSP73-XMyoD (Hopwood et al., 1989), pBS-XMyf5 (Gawantka
et al., 1998; Hopwood et al., 1991), M-Cadherin (IMAGE ID 5440166,
ATCC), XSEB-4 (IMAGE ID 4970239, ATCC), Actin alpha (IMAGE ID
5542285, ATCC), and Tnnc1 (IMAGE ID 4407474, ATCC). Antisense
RNA probe was generated in vitro using SP6, T7 or T3 RNA polymerase
(Ambion) and labeled with digoxigenin-11-UTP (Roche). Whole
mount in situ hybridization was performed on the ﬁxed and X-gal
stained embryos as described (Harland, 1991; Kanekar et al., 1997).
Immunostaining
For whole mount immunostaining, pigmented embryos were
bleached with 1% hydrogen peroxide and 5% formamide in 0.5X SSC
solution under ﬂuorescent light for about 1 h. The bleached embryos
were ﬁxed again with 4% PFA. 12/101 antibody hybridoma superna-
tant was used to stain differentiated skeletal muscle (Developmental
Studies Hybridoma Bank, (Kintner and Brockes, 1984)). After washing
embryos three times (1 h per wash) with PBS at 4 °C, embryos were
incubated with blocking solution containing 1% triton X-100 and 10%
heat inactivated goat serum in PBS for 3 to 5 h at RT. 12/101 antibody
and β-galactosidase antibody were diluted in the blocking solution
(1:300) and incubated for 2 to 4 days at 4 °C. The embryos were then
washed three times (1 hour per wash) with the blocking solution, and
Fig. 1. Conﬁrmation of candidate EBF targets by RT-PCR. hGR-Xebf3 mRNA and Noggin
mRNA were injected into embryos at the single-cell stage. At the blastula stage, the
animal caps were dissected then divided into two groups and either treated with DEX
or left as untreated controls. Following a 4.5 hour incubation, total RNA was isolated
and RT-PCR performed. The column labeled —RT is a negative control in which reverse
transcriptase was omitted at the cDNA synthesis step. Total embryo (TE) cDNA from
stage 12 (formyf5, brachyury and histone h4) or stage 27 (for the remaining genes) was
used as a positive RT-PCR control. brachyury was analyzed to ensure there was no
mesoderm contamination in animal caps. histone h4 was used as a loading control. All
tested genes (except the loading and contamination controls) were upregulated in the
presence of DEX.
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(Invitrogen) and alexa 568 conjugated goat anti-rabbit IgG secondary
antibody (Invitrogen) were diluted in the blocking solution (1:1000)
and incubated with embryos for 2 days at 4 °C. The embryos were
washed with PBS three times and were then photographed.
Real-time quantitative PCR
For real-time quantitative PCR (RT-QPCR) experiments, 1 ng hGR-
XEBF3mRNAwas injected intoXenopus embryos at the one-cell stage and
animal caps were isolated at stage 9. The animal caps were divided into
four groups. The control group received no treatment (−C−D). The
second group was treated with 30 μM DEX alone for 3 h (−C+D), and
the third group was treated with 5 μg/ml cycloheximide (CHX) alone for
3.5 h (+C−D). Finally, the fourthgroupwas treatedwith5 μg/mlCHXfor
30 min and then 30 μMDEXwas added for 3 h (+C+D). Total RNAwas
puriﬁed from animal caps as described above.
The Superscript III Platinum two-step RT-QPCR kit and SYBR Green
(Invitrogen) were used to make cDNA and to generate the PCR
solution, and RT-QPCR was performed on a 7900HT Real Time PCR
system (Applied Biosystems). The relative gene expression levels
were determined by normalizing the expression level of each gene to
the expression level of histone H4. Finally, expression levels were
normalized by setting the expression level in the condition of−C+D
to 100.
Results
EBF3 drives expression of multiple muscle development genes in explanted
Xenopus animal caps
To identify transcriptional targets of EBF3, we performed a
microarray screen on Xenopus animal cap explants, comparing animal
cap explants with and without active EBF3 protein ((Green and
Vetter, 2011) and see GEO database: GSE25734 and GSE27084). A
hormone-inducible fusion protein (hGR-XEBF3) was used to allow
regulation of EBF activity using the hormone dexamethasone (DEX).
In the absence of DEX, EBF3 remains inactive, but adding DEX to the
explants induces EBF3 activity (Kolm and Sive, 1995). Originally the
aim of the microarray was to identify neuronal-speciﬁc targets of EBF
activity, so we used Noggin to neuralize the animal caps (Lamb et al.,
1993). Nonetheless, we found a number of non-neuronal genes to be
upregulated by EBF3 activity in the microarray screen ((Green and
Vetter, 2011) and GEO: GSE25734). We have performed an additional
microarray screen without Noggin, and obtained similar results
((Green and Vetter, 2011) and GEO: GSE27084). We found that
genes involved inmuscle development were among themost strongly
upregulated genes on the array, with myod being the second most
strongly upregulated target of all genes. The candidate targets with
expected neuronal functions are described elsewhere (Green and
Vetter, 2011).
We founda variety of candidate targets that have known functionsor
expression inmuscle tissue (Green andVetter, 2011), andweperformed
additional analysis on six of these:myod (80-fold upregulated, Genbank
accession number BC073672), muscle-cadherin (m-cadherin, also called
as cadherin 15, 39-fold, CF288050), actin, alpha skeletal muscle (actin
alpha, also called as acta1, 34-fold, BC046739), seb-4 (also called as
rbm24, 16-fold, BC072812), cardiac troponin c (tnnc1, 9-fold, BC082829),
and myf5 (6-fold, AJ009303). These results are the ﬁrst to show myod
transcriptionally regulated by an EBF family member, and suggest a
potentially critical role of EBF proteins in Xenopusmuscle development.
To conﬁrm ourmicroarray results, we performed RT-PCR and found that
each candidate target gene listed above was upregulated in animal cap
explants in the presence of active hGR-XEBF3 (Fig. 1). To ensure that
Noggin is not responsible for the expression of the candidate targets, we
performed RT-PCR controls showing that myod can be upregulated byXebf3 in the absence of Noggin, and that Noggin alone does not induce
myod expression (Supplemental Fig. 1).
EBF2 and EBF3 are expressed in developing muscle tissue
EBF2 is another known EBF family member in Xenopus, and the
function of EBF2 is known to be similar to that of EBF3, so EBF2 was also
included in the remaining experiments of this study (Dubois et al., 1998;
Pozzoli et al., 2001). Previous studies in Xenopus have focusedmainly on
neuronal expression of the ebf2 and ebf3 genes (Dubois et al., 1998;
Pozzoli et al., 2001), but it has been reported that ebf2 is expressed in
Xenopusmuscle by Northern blot (Dubois et al., 1998) and there is also
apparent expression of ebf3 in somites of stage 28 and stage 32 Xenopus
embryos (Pozzoli et al., 2001). Since we have found that EBF activity
could drive the expression of our muscle speciﬁc candidate target genes
in animal cap explants, we performedwholemount in situ hybridization
(WM-ISH) to obtain a more detailed picture of both ebf2 and ebf3
expression in somites and developingmuscle tissue (Fig. 2). At stage 22,
there is expression of ebf2 and ebf3 in presomitic mesoderm tissue
(Figs. 2A, D; yellow arrows). Expression of ebf2 and ebf3 is detectable in
somites as well (Figs. 2A, D; black arrows), and this somite expression
becomes very clear at stage 28 (Figs. 2B, E; black arrows). The somites
will give rise to structures including dorsal epaxial muscle and ventral
hypaxial muscle. At stage 37, ebf2 and ebf3maintain somitic expression,
and maintain expression in the migrating hypaxial muscle tissue
(Figs. 2C, F; arrowheads). These expression patterns are consistent
with a role for ebf2 and ebf3 in regulating skeletal muscle development.
EBF2 and EBF3 are involved in Xenopus muscle development
In order to determine if EBF2 andEBF3 have a functional requirement
in Xenopus muscle development, we assessed development after
inhibiting the function of EBF2 and EBF3 using two different approaches.
First, antisensemorpholinos (MO)were used to block translation of ebf2
and ebf3 (EBF2 MO and EBF3 MO). Controls demonstrating the
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report (Green and Vetter, 2011). Second, a truncated dominant negative
EBF (NLS-DN-EBF) construct was used, which blocks the function of
endogenous EBF proteins by forming non-functional dimers that do not
bindDNA (Green andVetter, 2011), and (Dubois et al., 1998; Hagman et
al., 1993; Hagman et al., 1995)). In this construct, the putative nuclear
localization signal (NLS) (Wang and Reed, 1993) of EBF3 was deleted
alongwith the DNA binding domain, and replaced with the NLS of SV40
large T antigen. Either theMOs or NLS-DN-EBFmRNAwere injected into
two vegetal cells of eight-cell stage embryos, which make minimal
contributions to neuronal tissue where EBF factors are also known to be
required (Dubois et al., 1998; Green and Vetter, 2011; Pozzoli et al.,
2001). We then examined the expression pattern of the skeletal muscle
marker myod (Dosch et al., 1997; Hopwood et al., 1989; Martin and
Harland, 2001) at stage 39/40 (Figs. 3, A–H) by using WM-ISH.
After MO knockdown of EBF2 and EBF3, the migrating hypaxial
muscle anlagen were reduced, and the remaining anlagenmigrated a
shorter distance (Figs. 3D, F, H; black arrowheads) than on the
uninjected side. The chevron shape of somites was more irregular
(Figs. 3D, F, H; black arrows) than the uninjected side, and myod
expression levels in jaw muscle were downregulated (Figs. 3D, F, H;
yellow arrows). These defects of muscle development were present
following single knockdown of either EBF2 or EBF3, and were more
severe after double knockdown of both. Therewere no visible defects
after injection of control MO (Figs. 3, A and B). Since myod is one of
our candidate targets of EBF activity, we veriﬁed our ﬁndings by
labeling embryos with an antibody against the differentiated skeletal
muscle marker 12/101 ((Kintner and Brockes, 1984) and Figs. 3, I–L).
At stage 39/40, skeletal muscle tissue staining positively with 12/101
antibody can be seen in somites, jaw, and abdomen. Control MO
slightly delays hypaxial muscle differentiation, but does not affect
overall muscle differentiation (Figs. 3, I and K). However when EBF2
MO and EBF3 MO were coinjected, the region of skeletal muscle
tissue was reduced in jaw (Fig. 3L; yellow arrows) and abdomen
(Fig. 3L, white arrowheads) compared to the uninjected side
(Fig. 3K). In the somite region, the segmentation between somites
was not clear, and the chevron shape was abnormal (Fig. 3L, white
arrows). We found similar defects of skeletal muscle differentiation
after injection of NLS-DN-EBF (data not shown). These defects of
muscle development after knockdown of EBF2 and EBF3 give us good
evidence that EBF proteins are required for normal Xenopus skeletal
muscle development.Fig. 2. Expression patterns of ebf2 and ebf3 in Xenopusmuscle. ebf2 (A–C) and ebf3 (D–F) are e
expressed in pre-somitic mesoderm (yellow arrows). At all three stages, ebf2 and ebf3 are exp
the migrating hypaxial muscle anlagen (arrowheads).Classes and expression patterns of candidate target genes
Since the loss-of-function experiments demonstrated that EBF
activity is required for Xenopus muscle development, we wished to
further analyze the candidate EBF targets with possible roles in
muscle development. First, they were classiﬁed based on their known
functions in Xenopus and other species. MYOD and MYF5 are basic
helix–loop–helix (bHLH) transcription factors and also are myogenic
regulatory factors (MRF) (Braun et al., 1989; Davis et al., 1987;
Hopwood et al., 1989; Hopwood et al., 1991); M-Cadherin is a cell
membrane protein (Donalies et al., 1991); skeletal muscle alpha actin
composes the core of the thin ﬁlament of the sarcomere in muscle;
SEB-4 is an RNA binding protein (Fetka et al., 2000); and TNNC1
(cardiac troponin C) is a member of the EF-hand Ca2+ binding protein
family (Yuasa et al., 1998).
We next compared the expression domains of these candidate
target genes (Fig. 4) with those of ebf2 and ebf3 (Fig. 2) by WM-ISH at
stage 35–37. We chose this stage because most structures that will
give rise to skeletal muscles, including somites (black arrows),
migrating hypaxial muscle anlagen (black arrowheads) and develop-
ing jawmuscle (yellow arrows), are clearly detectable at this stage. All
six genes are expressed in the tissues that will give rise to skeletal
muscle ((Dosch et al., 1997; Fetka et al., 2000; Hopwood et al., 1989;
Hopwood et al., 1991; Martin and Harland, 2001) and Fig. 4). myod is
expressed in a strong central band in the somites, with especially
strong expression at the dorsal and ventral lips. It is also expressed in
jaw muscle and migrating hypaxial muscle anlagen (Dosch et al.,
1997; Martin and Harland, 2001), and Fig. 4A). m-cadherin is
expressed in a weaker central band in the somites, and with diffuse
expression throughout the somites. It is also expressed in jaw muscle
and migrating hypaxial muscle anlagen (Fig. 4B). The expression
patterns of actin alpha and seb-4 in muscle tissue are very similar to
that of myod. They are expressed in the somites, jaw muscle and the
migrating hypaxial muscle anlagen ((Fetka et al., 2000; Sturgess et al.,
1980) and Figs. 4, C and D). tnnc1 is expressed in the somites at this
stage (Fig. 4E). myf5 is expressed in the somites, jaw muscle and
migrating hypaxial muscle anlagen, but the expression pattern of
myf5 is different from other candidate targets in the migrating
hypaxial muscle anlagen, in that it appears to be at the leading edge,
rather than within the bulk of the anlagen. Expression of myf5 is also
weaker than that of the other candidate targets at this stage ((Dosch
et al., 1997; Martin and Harland, 2001) and Fig. 4). actin alpha, seb-4xpressed inmultiple developing neural andmuscle tissues. At stage 22, ebf2 and ebf3 are
ressed in the developing somites (black arrows). At stage 37, they are also expressed in
Fig. 3. Defective skeletal muscle development after knockdown of EBF2 and EBF3. Two vegetal cells of eight-cell stage embryos were injected with control MO or EBF2 MO (2 MO)
and EBF3 MO (3 MO), either alone or together. β-gal mRNA was coinjected as a marker of the injected side (light blue). At stage 39/40, myod expression was examined (A–H), and
12/101 antibody was used as a marker of skeletal muscle tissue (I-L). The left column (A, C, E, G, I, and K) shows the uninjected control side of the embryos. The right column (B, D, F,
H, J, and L) shows the injected side, and (B and F) in some embryos there is more light blue staining in the pronephros, the functional larval kidney, which largely develops from the
two vegetal cells that we targeted (Moody, 1987). All panels show lateral views. After injection of 2MO or 3MO,myod expression patterns show that the chevron shape of somites is
abnormal (black arrows), the hypaxial muscle anlagen are smaller, and the migration distance is reduced (black arrowheads), compared to the uninjected side. The expression of
myod in jawmuscle is also reduced (yellow arrows). When 2 MO and 3 MOwere coinjected (H), these defects were more severe than 2 MO or 3 MO alone (D and F). Control MO has
no effect (B). 12/101 antibody staining shows that when 2MO and 3MOwere coinjected, somite segmentation is not complete, and the chevron shape of somites is abnormal (white
arrows). Also jaw muscle differentiation is reduced (yellow arrow) and abdominal hypaxial muscle differentiation is strongly reduced (white arrowheads), while control MO shows
a mild defect of only hypaxial muscle differentiation (J). To visualize the injected side after immunostaining, β-galactosidase antibody (not shown) was used for coimmunostaining
along with 12/101 antibody.
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Fig. 4. Expression patterns of muscle target genes. In stage 35–37 embryosmyod, m-cadherin, actin alpha, seb-4, tnnc1 andmyf5 are all expressed in skeletal muscle including somites
(black arrows), migrating hypaxial muscle anlagen (black arrowheads) and jawmuscle (yellow arrows).myod, m-cadherin, actin alpha, seb-4, andmyf5 (A-D and F) are expressed in
the somites, migrating hypaxial muscle anlagen and jaw muscle, and these expression patterns overlap with those of ebf2 and ebf3 (Fig. 2). m-cadherin (B) is weakly expressed in a
central band in somites, with expression throughout the somite. myf5 (F) expression in somites is weaker than other genes at this stage, and is expressed at the leading edge of
migrating hypaxial muscle. tnnc1 (E) is expressed in the somites. actin alpha, seb-4, and tnnc1 are expressed in the heart (yellow arrowheads). All embryos show lateral views.
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(Figs. 4 C–E, yellow arrowheads). These skeletal muscle expression
patterns of myod, m-cadherin, actin alpha, seb-4, tnnc1 and myf5 are
very similar to expression of ebf2 and ebf3, including expression in
somites and migrating hypaxial muscle anlagen. This strong correla-
tion suggests that the candidate targets we have identiﬁed by
microarray could be in vivo targets of EBF activity during Xenopus
muscle development.
EBF2 and EBF3 are sufﬁcient and required for the expression of muscle
candidate targets in vivo
Todetermine if EBF2 and EBF3 are sufﬁcient for driving the expression
of the candidate target genes in vivo, we examined the expression level of
candidate targets after overexpression of hGR-XEBF2 or hGR-XEBF3 in
Xenopus embryos. Overexpression was achieved by injection of mRNA
into one cell of two-cell stage embryos, followed by treatment of the
embryos with DEX from the gastrula stage (stage 11/11.5) to the neurula
stage (stage 14/15) (about 6–8 h at room temperature). We found that
overexpression of EBF2 or EBF3 caused upregulation of myod (16/16
embryos for hGR-XEBF2 and 16/16 embryos for hGR-XEBF3),m-cadherin
(28/33 and 15/24), seb-4 (18/18 and 24/24), andmyf5 (33/50 and 30/48)
(Figs. 5, A–L, brackets), which supports themicroarray data, and suggests
that EBF activity is sufﬁcient to drive expression of these candidate genes
in vivo. However, the expression of actin alpha (17/24) and tnnc1 (36/48)
was downregulated by EBF3 (Figs. 5, M–P, brackets) suggesting that actin
alpha and tnnc1 are not positively regulated by EBF activity in vivo at these
early developmental stages. Tomore closelymimic the stages used for the
animal caps for the microarray screen and to test for stage-dependent
effects, we repeated the experiment but incubated with DEX from the
blastula stage (stage 9), for 4.5 h (to the gastrula stage (stage 10.5–11)),
exactly as was done for the microarray. Consistent with the previous
conditions, myod (27/27), seb-4 (24/26) and myf5 (27/30) were
upregulated by EBF3 (data not shown). Actin alpha (28/28) and tnnc1(25/25) were not upregulated by EBF3, consistent with the conclusion
that these genes are not regulated by EBF activity in vivo at these stages.
However, in contrastwith theprevious experiment theexpression level of
m-cadherin was not upregulated (26/26), suggesting that a longer
induction period or a later developmental stage may be required for
this gene to be induced by EBF activity in vivo.
Todetermine if EBF2andEBF3 activity is required for the expressionof
the four upregulated candidate target genes in vivo, we examined their
expression level after knockdownof EBF2 andEBF3, targeting both factors
together since they often act redundantly. To block EBF2 and EBF3
function, EBF2MO and EBF3MOwere coinjected into two vegetal cells of
eight-cell stage embryos. The endogenous expression level of candidate
target genes was examined at the early tail bud stage (stage 20/21), a
stage inwhich the anterior somites are clearly formed, and the expression
of each target is apparent (Fig. 6). After knockdown of both EBF2 and
EBF3, the expression of myod (16/18 embryos), m-cadherin (7/8), seb-4
(6/10), and myf5 (14/17) were downregulated (Figs. 6, B, E, H, and K,
brackets). ControlMOdid not change the expression levels of these genes
(Figs. 6, A, D, G, and J). These four genes were also downregulated by
expression of NLS-DN-EBF; MyoD (16/17), m-cadherin (15/15), seb-4
(16/18), myf5 (12/17) (Figs. 6, C, F, I, and L, and brackets). These
knockdown experiments suggest that EBF factors are required for the
expression of each of our candidate targets in vivo.
Previously we have shown that EBF2 MO and EBF3 MO speciﬁcally
block EBF activity during Xenopus neuronal development (Green and
Vetter, 2011). To demonstrate the speciﬁcity of the MOs during muscle
development, we performed anmRNA rescue experiment. EBF2MO and
EBF3 MOwere coinjected with hGR-XEBF2 mRNA, which does not have
overlapping sequence with theMOs, and then half of the embryos were
treatedwithDEX from the gastrula stage (stage 11.5) to the early tailbud
stage (stage 20) and the other half were used as controls. Compared to
the strong downregulation of m-cadherin seen with morpholino alone
(19/25), the expression level ofm-cadherinwas rescued in the presence
of active hGR-XEBF2 (20/24) (Figs. 6, M and N). This data demonstrates
Fig. 5. EBF2 and EBF3 are sufﬁcient for muscle target gene expression. hGR-XEBF2 or
hGR-XEBF3 mRNA were injected into one cell of two-cell stage embryos, followed by
DEX treatment from the late gastrula stage (stage 11/11.5) to the neurula stage (stage
14/15). hGR mRNA was injected in control embryos. β-gal mRNA was coinjected as a
marker of the injected side. In all panels the right side is the injected side, showing the
blue color of X-gal staining. The (purple) expression levels of myod (B and C), m-
cadherin (E and F), seb-4 (H and I), andmyf5 (K and L) are strongly upregulated by EBF2
and EBF3 (brackets), while expression of hGR alone does not change the expression
level of the target genes (A, D, G, and J). The expression of actin alpha (N) and tnnc1 (P)
is downregulated by EBF3. All panels show dorsal views.
Fig. 6. EBF2 and EBF3 are necessary for muscle target gene expression. (A–L) Two
vegetal cells of eight-cell stage embryos were injected with either XEBF2MO and XEBF3
MO together, or control MO. β-gal mRNA was coinjected as a marker of the injected
side. The expression level of target genes was examined at stage 20/21. In all panels the
right side is the injected side, showing the blue color of X-gal staining. The (purple)
expression levels ofmyod (B and C),m-cadherin (E and F), seb-4 (H and I), and myf5 (K
and L) are downregulated by XEBF2 MO and XEBF3 MO together or by NLS-DN-EBF
(brackets), while control MO does not change their expression levels (A, D, G, and J).
(M, N) Two vegetal cells of eight-cell stage embryos were coinjected with XEBF2 MO,
XEBF3 MO and hGR-XEBF2 mRNA, followed by DEX treatment from the late gastrula
stage (stage 11/11.5) to the early tailbud stage (stage 20). The expression ofm-cadherin
is downregulated without EBF activity (M), but expression was rescued in the presence
of EBF activity (N). All panels show dorsal views.
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Xenopus muscle development. The disrupted somite segmentation
caused by the morpholinos was not rescued, but this is not surprising
since we have found that somite segmentation can be disrupted by both
gain and loss of EBF activity.
EBF3 can induce the expression of myod and myf5 in the absence of
protein synthesis
We next determined if EBF proteins can drive the expression of the
four candidate targets directly, in the absence of protein synthesis.Brieﬂy, we prepared animal caps expressing hGR-XEBF3 then added
cycloheximide (CHX), an inhibitor of protein synthesis, prior to DEX
treatment (see also (Green and Vetter, 2011)). Animal caps were
collected at stage 9 and divided into four groups: untreated controls
(−C−D), DEX alone (−C+D), CHX alone (+C−D), and both CHX
and DEX (+C+D). The expression levels of the four candidate targets
were then examined by RT-QPCR (Fig. 7).
The expression level of myf5 in the condition of +C+D was
comparable to the condition of−C+D (Fig. 7A), which suggests that
myf5 is a direct target. The expression level ofmyod in the condition of
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of −C+D (Fig. 7B), which suggests that EBF3 primarily drives the
expression of myod directly, but that there may also be an indirect
component. The expression level of m-cadherin in the condition of
+C+D was similar to the two control conditions,−C−D and +C–D
(Fig. 7C), so we conclude that m-cadherin is likely to be an indirect
target of EBF3. Finally the results for seb-4 were inconclusive since
the expression level of seb-4 in the condition of +C+D is similar to
the expression level in the condition of−C+D but also similar to the
expression level in one control condition, +C−D (Fig. 7D).
MYOD can upregulate the expression of ebf2 and ebf3 in vivo in a positive
feedback loop
In Drosophila, the MYOD ortholog Nautilus can drive expression of
the ebf ortholog collier (Dubois et al., 2007). We therefore asked
whether MYOD can also regulate ebf gene transcription in Xenopus.
MYOD-hGR (Kolm and Sive, 1995) mRNAwas injected into one cell of
two-cell stage embryos, followed by treatment of embryos with DEX
from the gastrula stage (stage 11/11.5) to the neurula stage (stage
14/15). The expression levels of ebf2 and ebf3were then examined by
WM-ISH. The expression levels of both ebf2 and ebf3 wereFig. 7. The identiﬁcation of direct and indirect candidate targets of EBF3. hGR-XEBF3
mRNA was injected into one-cell stage embryos, and animal caps were collected at the
blastula stage (stage 9). The animal caps were divided into four groups, based on CHX
and DEX treatment:−C−D,−C+D, +C−D, and+C+D. After a 3.5-hour incubation
with CHX and/or a 3-hour incubation with DEX, total RNA was isolated from the animal
caps and RT-QPCR was conducted with the isolated RNA. The expression level was
normalized with the expression level of histone h4 and then normalized to the
expression level of−C+D, for each gene, at 100 arbitrary units. The expression level of
myf5 in the condition of +C+D is comparable to the condition of−C+D (A) and the
expression level ofmyod in the condition of +C+D is only partially reduced compared
to the condition of −C+D (B). The expression level of m-cadherin in the condition of
+C+D is similar to the levels of the two control conditions (C). The expression level of
seb-4 in +C+D is similar to the expression level in −C+D but also similar to the
expression level in one control condition, +C−D so it is not conclusively a direct or
indirect target of EBF activity. Error bars represent standard error of the mean. N=5
replicates, 20 to 30 animal caps per condition.upregulated by activated MYOD (31/31 for ebf2 and 19/19 for ebf3,
Fig. 8, brackets). Combined with our result that EBF activity directly
drivesmyod expression, this suggests that MYOD and EBF may have a
reciprocal transcriptional interaction in vertebrates.
Since we found above that m-cadherin is an indirect target of EBF
activity, and since MYOD and EBF appear to have a reciprocal
transcriptional relationship in Xenopus embryos, we next examined
whether MYOD could restore m-cadherin expression, which is normally
lost when EBF activity is blocked. We coinjected EBF2 MO and EBF3 MO
with MYOD-hGR mRNA, and treated with DEX to activate MYOD. While
the expression level of m-cadherin was strongly downregulated by the
morpholinos in the absence of activeMYOD(8/12), the expression level of
m-cadherinwas rescued in thepresenceof activeMYOD(14/18), (Figs. 8, E
and F). This data is consistent with results showing that m-cadherin is a
direct target of MYOD in Xenopus embryos (Hsiao and Chen, 2010).
Overall, these results suggest thatm-cadherin expression is dependent on
both EBF activity and MYOD activity, and that EBF acts through MYOD to
promotem-cadherin expression.
Discussion
While EBF proteins have well documented roles in neural and B cell
development, nothing has been reported about their role in muscle
development in vertebrates. Our ﬁndings that the ebf2 and ebf3 genes
are extensively expressed in developing muscle tissue in Xenopus, andFig. 8. MYOD drives expression of ebf2 and ebf3. (A–D) MYOD-hGR mRNA or control,
hGR mRNA was injected into one cell of two-cell stage embryos, followed by DEX
treatment from the late gastrula stage (stage 11/11.5) to the neurula stage (stage
14/15). β-gal mRNA was coinjected as a marker of the injected side. In all panels the
right side is the injected side, showing the light blue color of X-gal staining. The
expression of ebf2 (B) and ebf3 (D) is strongly upregulated by activated MYOD-hGR
(brackets), while control hGR injection does not change the expression level of ebf2 (A)
or ebf3 (C). All panels show dorsal views. (E, F) Two vegetal cells of eight-cell stage
embryos were co-injected with XEBF2 MO, XEBF3 MO and MYOD-hGR mRNA, followed
by DEX treatment from the late gastrula stage (stage 11/11.5) to the early tailbud stage
(stage 20). The expression level ofm-cadherin is downregulated without MYOD activity
(E), but the expression level was rescued in the presence of MYOD activity (F).
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reveal an unexpected role for EBF transcription factors in vertebrate
muscle development. We have identiﬁed multiple genes, with known
function in muscle tissue, to be downstream of EBF transcriptional
activity. These genes represent potential routes whereby EBF activity
can help regulate commitment, differentiation, andmigration of muscle
cells. The candidate target genes that were found in the microarray
screen (seeGreen andVetter, 2011, andGEOdatabaseGSE25734;www.
ncbi.nlm.nih.gov/geo/) but that we did not test further in vivo also open
additional potential routes for exploration of EBF activity duringmuscle
development.
EBF proteins function in muscle cell determination to drive myod and
myf5 expression directly
Our discovery that MYOD and MYF5 appear to be direct candidate
transcriptional targets of EBF activity demonstrates a potentially
important role for EBF proteins in muscle cell determination. MRFs
including MYOD, MYF5, Myogenin and MRF4 are bHLH transcription
factors that form heterodimers with other bHLH proteins, such as the
ubiquitously expressed E proteins. These MRFs are critical for driving
transcription of muscle-related genes (Biressi et al., 2007; Buckingham,
2001; Chanoine andHardy, 2003; Pownall et al., 2002; Shih et al., 2008).
In particular, MyoD, Myf5 double knockout mice display a complete
absence of muscle cells (Rudnicki et al., 1993).
In this study we show that in Xenopus myod andmyf5 are candidate
targets of EBF proteins, and that ebf2 and ebf3 can in turn be regulated by
MYOD.MYOD is expressed in early presomitic mesoderm. ebf2 and ebf3
are detected byWM-ISH in pre-somiticmesodermaswell, but not at the
early stages when myod is present. This suggests that EBF proteins are
likely involved in maintaining and reinforcing the expression of myod
rather than initiation of myod expression. Maintenance of myod
expression by EBF proteins appears to be important in Xenopus, since
we ﬁnd that knockdown of EBF activity strongly reduces the expression
of myod, and disrupts normal skeletal muscle development, including
that of somites, hypaxial muscle and jaw muscle. Our study therefore
suggests that EBF proteins are involved in Xenopus myogenic determi-
nation bymaintaining and reinforcing the expression ofmyod andmyf5.
It is known that MYOD also can drive its own expression (Thayer et al.,
1989; Weintraub et al., 1989), but in Xenopus this auto-regulation of
MYOD may need to be reinforced by EBF regulation to give proper
myogenic speciﬁcation.
Our ﬁnding, conversely, that MYOD drives expression of ebf genes
is analogous to the ﬁnding in Drosophila that the MYOD ortholog
Nautilus drives collier expression (Dubois et al., 2007). In mouse, no
muscle phenotype has been reported for knockouts of Ebf genes.
However, there is redundancy of function for the Ebf genes, and since
no Ebf1/Ebf2/Ebf3 triple knockout mouse has been described, the full
contribution of EBF activity to mouse muscle development remains
unknown. However, in two types of microarray screens for MYOD
targets in mouse cultured cell lines, Ebf expression was either
unchanged or even downregulated (Bergstrom et al., 2002). Also,
Ebf genes were not found to be a MYOD target by ChIP analysis in a
mouse cultured cell line (Cao et al., 2006). The fact that our ﬁndings
are analogous to Drosophila but somewhat at odds with these
microarray and ChIP experiments in mouse cultured cell lines could
be due to species differences or to differences in experimental design.
Thus, it remains to be determined whether EBF proteins play a role in
muscle development in other vertebrate species.
EBF proteins function in muscle cell differentiation to drive m-cadherin
and seb-4 expression
We show that knockdown of EBF activity leads to delayedmigration
of hypaxial muscle anlagen, defective somite organization, and reduced
differentiation of skeletal muscle. The known functions of M-Cadherinand SEB-4 suggest that EBF proteins may control aspects of myoblast
migration and differentiation through regulation of these and possibly
additional target genes. However, MYOD and otherMRFs can drive both
m-cadherin expression and seb-4 expression (HsiaoandChen, 2010; Li et
al., 2010), and we found that EBF regulation of m-cadherin was likely
indirect. Thus it seems likely that some aspects of muscle gene
regulation by EBFs occur indirectly throughMYOD and possibly through
MYF5.
There is evidence that bothM-Cadherin and SEB-4 could function as
important downstream effectors of EBF activity in muscle cell
development. M-Cadherin is an adhesion protein that is present in
developing and adult skeletal muscle, and at the adult neuromuscular
junction. During development, it is known to be involved in the
differentiation of skeletal muscle, with special importance for myoblast
fusion (Charrasse et al., 2007; Cifuentes-Diaz et al., 1996; Donalies et al.,
1991; Moore and Walsh, 1993; Pouliot et al., 1994; Zeschnigk et al.,
1995). There are also reports of its involvement inmuscle cell migration
in zebraﬁsh somites (Cortes et al., 2003), and of its association with
microtubules in a myoblast cell line (Kaufmann et al., 1999). Since we
ﬁnd that m-cadherin is expressed in Xenopus from as early as the pre-
somitic mesoderm period and continuing through the events of muscle
differentiation, it is possible that it is involved in steps including somite
formation, hypaxial muscle migration, and maintenance of proper cell
relationships during late myoblast differentiation.
It has been shown that the RNA binding protein SEB-4 is necessary
for myogenesis (Li et al., 2010; Miyamoto et al., 2009). SEB-4 is likely
involved in regulation of cytoskeletal events in muscle development,
since it is a Xenopus homolog of the C. elegans protein SUP-12, which
regulates splicing of unc-60mRNA (Anyanful et al., 2004). UNC-60 is the
ortholog of actin depolymerizing factor (ADF)/coﬁlin which controls
actin ﬁlament dynamics (Bamburg, 1999; Bamburg et al., 1999;Maciver
and Hussey, 2002). The seb-4 gene is expressed in the presomitic
mesoderm from gastrulation, and its expression is restricted to somites,
jaw muscle and myocardium at the tailbud stage ((Fetka et al., 2000)
and Fig. 4). Since it is expressed at the somite stage, and since somite
rotation in Xenopus involves actin rearrangement (Kragtorp and Miller,
2006), seb-4may be necessary for proper somite rotation.
The transcriptional relationship between EBF proteins and bHLH proteins
Our systematic study of transcriptional targets of EBF proteins,
togetherwith evidence fromother reports andother species, is expanding
the scope of evidence for reciprocal transcriptional relationships between
EBF proteins and bHLH proteins involved in cell commitment and
differentiation in multiple cell lineages. First, during neuronal develop-
ment EBF proteins have been shown to act upstream of bHLH genes in
multiple contexts. For example, EBF2 can drive expression of the
proneural bHLH genes ngnr-1 and neurod in Xenopus (Dubois et al.,
1998; Pozzoli et al., 2001). Additionally, misexpressed mouse Ebf1 drives
expressionofngn1 andngn2 in chick spinal cord (Garcia-Dominguez et al.,
2003). We also recently found that the bHLH gene nscl-1 is transcription-
ally regulated by EBF activity (Green and Vetter, 2011). These ﬁndings
show striking similarity to what we report here, namely that the bHLH
genesmyod andmyf5 are regulated by EBF2 and EBF3.
Conversely, there is also evidence that bHLH proteins can drive
expression of ebf genes in multiple contexts. For example, in Xenopus,
the bHLH transcription factors NGNR-1, NeuroD and ATH5 can
upregulate ebf2 and ebf3 (Dubois et al., 1998; Logan et al., 2005;
Pozzoli et al., 2001; Seo et al., 2007), and misexpressed ngn2 drives
ebf1 and ebf3 expression in chick spinal cord (Garcia-Dominguez et al.,
2003). In Drosophila, Nautilus drives collier expression (Dubois et al.,
2007). Analogously, our current study shows that MYOD can drive
expression of ebf2 and ebf3 in Xenopus embryos.
These studies support the idea that EBF proteins and bHLH
proteins have reciprocal transcriptional relationships in multiple
lineages. Because EBF proteins and bHLH proteins appear to control
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and muscle tissues, and possibly in multiple species, we believe that
there may be an ancient transcriptional relationship between these
two gene families. Evidence also exists of reciprocal relationships
between EBF and bHLH proteins in B cell development (Greenbaum
and Zhuang, 2002; Kee and Murre, 1998; Kwon et al., 2008; Seet et al.,
2004; Smith et al., 2002; Zhuang et al., 2004). All of these relationships
appear to be primarily centered on stabilizing commitment of cells to
a particular lineage. Interestingly, the potential spectrum of activities
in muscle tissue suggested by our experiments, including stabilizing
commitment, directing migration, and directing cytoskeletal organi-
zation, is very analogous to the range of activities driven by EBF
proteins in neural development.
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